{
  "approved_at_utc": null,
  "subreddit": "stocks",
  "selftext": "Lawmakers announced Friday an investigation into the approval and pricing of Biogen Inc's Alzheimer's drug, Aduhelm, amid concerns over its steep price and doubts if the clinical evidence proves the drug works. Three of the 11 members of FDA's independent advisory panel have resigned in protest over the agency's decision. [https://www.newsmax.com/politics/biogen-fda-approval-congress/2021/06/25/id/1026499/](https://www.newsmax.com/politics/biogen-fda-approval-congress/2021/06/25/id/1026499/)",
  "author_fullname": "t2_80hlmkao",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Congress to Probe Approval, Pricing of Biogen's Alzheimer's Drug",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/stocks",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": null,
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_o8drza",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.84,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 44,
  "total_awards_received": 1,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": null,
  "can_mod_post": false,
  "score": 44,
  "approved_by": null,
  "is_created_from_ads_ui": false,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1624752784,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.stocks",
  "allow_live_comments": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Lawmakers announced Friday an investigation into the approval and pricing of Biogen Inc&#39;s Alzheimer&#39;s drug, Aduhelm, amid concerns over its steep price and doubts if the clinical evidence proves the drug works. Three of the 11 members of FDA&#39;s independent advisory panel have resigned in protest over the agency&#39;s decision. <a href=\"https://www.newsmax.com/politics/biogen-fda-approval-congress/2021/06/25/id/1026499/\">https://www.newsmax.com/politics/biogen-fda-approval-congress/2021/06/25/id/1026499/</a></p>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qjfk",
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "",
  "id": "o8drza",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "badgebruce",
  "discussion_type": null,
  "num_comments": 3,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/stocks/comments/o8drza/congress_to_probe_approval_pricing_of_biogens/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/stocks/comments/o8drza/congress_to_probe_approval_pricing_of_biogens/",
  "subreddit_subscribers": 2837867,
  "created_utc": 1624776412,
  "num_crossposts": 0,
  "media": null,
  "is_video": false,
  "original_created_utc": 1624723984,
  "the_new_excerpt": "Lawmakers announced Friday an investigation into the approval and pricing of\nBiogen Inc's Alzheimer's drug, Aduhelm, amid concerns over its steep price and\ndoubts if the clinical evidence proves the drug works. Three of the 11 members\nof FDA's independent advisory panel have resigned in protest over…",
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "議員たちは金曜日、バイオジェン社のアルツハイマー病治療薬「アドゥヘルム」の承認と価格設定に関する調査を発表しました。\nバイオジェン社のアルツハイマー病治療薬「アドゥヘルム」の承認と価格について調査することを発表しました。\nバイオジェン社のアルツハイマー型認知症治療薬「アデュエルム」は、価格の高さや、薬の効果を証明する臨床的証拠があるのかどうか疑問視されている。11人のメンバーのうち3人は\nFDA（米国食品医薬品局）の独立諮問委員会のメンバー11名のうち3名が、この問題に抗議して辞任しました。",
      "title": "バイオジェン社のアルツハイマー型認知症治療薬の承認と価格を米国議会が調査"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "立法者周五宣布对百健公司的阿尔茨海默病药物Aduhelm的批准和定价进行调查。\n百健公司的阿尔茨海默氏症药物Aduhelm，因为人们对其昂贵的价格和临床证据是否有效表示担忧。\n怀疑临床证据是否证明该药物有效。11名成员中的3名\n美国食品和药物管理局独立咨询小组的三名成员已经辞职，以示抗议。",
      "title": "美国国会将调查百健公司阿尔茨海默病药物的批准和定价问题"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "立法者週五宣佈對百健公司的阿爾茨海默病藥物Aduhelm的批准和定價進行調查。\n百健公司的阿爾茨海默氏症藥物Aduhelm，因爲人們對其昂貴的價格和臨牀證據是否有效表示擔憂。\n懷疑臨牀證據是否證明該藥物有效。11名成員中的3名\n美國食品和藥物管理局獨立諮詢小組的三名成員已經辭職，以示抗議。",
      "title": "美國國會將調查百健公司阿爾茨海默病藥物的批准和定價問題"
    }
  ],
  "source_updated_at": 1625218969049
}